Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice

Chronic kidney disease (CKD) leads to uremia. CKD is characterized by a gradual increase in kidney fibrosis and loss of kidney function, which is associated with a progressive increase in risk of atherosclerosis and cardiovascular death. To prevent progression of both kidney fibrosis and atheroscler...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PLoS One
Main Authors: Bisgaard, Line S., Bosteen, Markus H., Fink, Lisbeth N., Sørensen, Charlotte M., Rosendahl, Alexander, Mogensen, Christina K., Rasmussen, Salka E., Rolin, Bidda, Nielsen, Lars B., Pedersen, Tanja X.
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2016
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5161477/
https://ncbi.nlm.nih.gov/pubmed/27992511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0168396
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki